Collagen I dysregulation is pivotal for ovarian cancer progression.

Sarwar, Makhdoom; Sykes, Peter H; Chitcholtan, Kenny; Evans, John J

Sarwar, Makhdoom; Sykes, Peter H; Chitcholtan, Kenny; Evans, John J.

Afiliação

Sarwar M; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, 2 Riccarton Avenue, Christchurch, 8011, New Zealand. Electronic address: mak.sarwar@otago.ac.nz.
Sykes PH; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, 2 Riccarton Avenue, Christchurch, 8011, New Zealand.
Chitcholtan K; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, 2 Riccarton Avenue, Christchurch, 8011, New Zealand.
Evans JJ; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, 2 Riccarton Avenue, Christchurch, 8011, New Zealand; MacDiarmid Institute of Advanced Materials and Nanotechnology, Christchurch, New Zealand.

Tissue Cell ; 74: 101704, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34871826

Assuntos

Colágeno Tipo I/biossíntese; Regulação Neoplásica da Expressão Gênica; Proteínas de Neoplasias/sangue; Neoplasias Ovarianas/metabolismo; Linhagem Celular Tumoral; Colágeno Tipo I/genética; Feminino; Humanos; Proteínas de Neoplasias/genética; Neoplasias Ovarianas/genética; Neoplasias Ovarianas/patologia

Palavras-chave

Biophysical ECM; Collagen architecture; ECM remodelling; ECM-mediated chemoresistance; Mechanotransduction; Ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Regulação Neoplásica da Expressão Gênica / Colágeno Tipo I / Proteínas de Neoplasias Limite: Female / Humans Idioma: En Revista: Tissue Cell Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google